A Dark Vector Cognition product

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

60K characters. Original on sec.gov ·

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The 10 tables in Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS as one CSV, figures in aligned columns. For subscribers: paste your API key. One API call. Plans from $19 a month, see pricing.

GENERAL

This discussion should be read in conjunction with the information contained in the Consolidated Financial Statements, and the accompanying notes elsewhere in this report. Unless otherwise indicated, the “Company,” “we,” “us,” “our” or similar words are used to refer to LyondellBasell Industries N.V. together with its consolidated subsidiaries (“LyondellBasell N.V.”).

OVERVIEW

Results from continuing operations for the third quarter of 2026 increased compared to the second quarter of 2026, as the second quarter results reflected a $734 million loss on the disposition of select European assets and the associated businesses. In our Olefins & Polyolefins-Americas (“O&P-Americas”) segment, profitability fell driven by lower prices for polymers and olefins products. In our Olefins & Polyolefins-Europe, Asia, International (“O&P-EAI”) segment, polymer prices fell which pressured margins. Volumes in the third quarter were also lower, reflecting the sale of certain European assets in May 2026. Our Intermediates and Derivatives (“I&D”) segment results increased driven by improvements in oxyfuels and related products as the Bayport PO/TBA site operated at full rates after a successful restart in June 2026 and global supply disruptions led to higher gasoline crack spreads and octane values.

Results from continuing operations for the first nine months of 2026 increased compared to the first nine months of 2025. In our O&P-Americas and O&P-EAI segments, margins improved due to industry supply constraints resulting from the conflict in the Middle East. In our I&D segment, margins improved primarily due to higher crude and gasoline crack spreads. During the first nine months of 2025, we recognized impairment charges of $1,234 million in our O&P-EAI and APS segments, primarily related to a prolonged downturn in, and outlook for, the European petrochemical and global automotive industries and combined decline in our market capitalization.

During the first nine months of 2026, we generated $2,199 million of cash from operating activities. We invested $842 million in capital projects, returned $672 million to shareholders through dividend payments and repaid the €500 million ($577 million) 0.875% guaranteed notes due 2026.

Results of operations for the periods discussed are presented in the table below:

Three Months EndedNine Months Ended
September 30,June 30,September 30,September 30,
Millions of dollars2026202620262025
Sales and other operating revenues$8,499$9,177$24,873$23,062
Cost of sales7,0037,13920,63820,820
Goodwill impairments———972
Other impairments—7489262
Selling, general and administrative expenses3943871,1921,237
Research and development expenses3534105103
Operating income (loss)1,0671,5432,849(332)
Interest expense(138)(138)(414)(355)
Interest income29248472
Loss on sale of business—(734)(734)(6)
Other income, net3566948
Income from equity investments25754—
Income (loss) from continuing operations before income taxes9638081,908(573)
Provision for income taxes18723642178
Income (loss) from continuing operations7765721,487(651)
Income (loss) from discontinued operations, net of tax(18)(13)(45)53
Net income (loss)7585591,442(598)
Other comprehensive income (loss), net of tax –
Financial derivatives34(5)71(10)
Defined benefit pension and other postretirement benefit plans3(14)(8)(1)
Foreign currency translations(8)291254190
Total other comprehensive income, net of tax29272317179
Comprehensive income (loss)$787$831$1,759$(419)

RESULTS OF OPERATIONS

Revenues—Revenues decreased by $678 million, or 7%, in the third quarter of 2026 compared to the second quarter of 2026. Lower average sales prices across many of our products reduced revenues by 12%, reflecting softening market conditions relative to the second quarter. This decrease was partially offset by a 6% increase in revenues from higher sales volumes, driven by the absence of unplanned outages in our I&D segment compared to the prior quarter. Unfavorable foreign exchange impacts reduced revenues by 1%.

Revenues increased by $1,811 million, or 8%, in the first nine months of 2026 compared to the first nine months of 2025. Higher average sales prices related to industry-wide supply constraints for many of our products drove a 12% increase in revenues. Lower sales volumes, attributable to the divestiture of certain European assets and the associated businesses, drove a 6% decrease in revenues. Favorable foreign exchange impacts contributed to a 2% increase in revenues.

Cost of Sales—Cost of sales decreased by $136 million, or 2%, in the third quarter of 2026 compared to the second quarter of 2026, and by $182 million, or 1%, for the first nine months of 2026 compared to the first nine months of 2025. Included in cost of sales were shutdown costs of $76 million in the third quarter of 2026 and $117 million in the first nine months of 2025 related to the permanent closure of our European PO joint venture. The remaining decrease for each period was driven by lower feedstock costs attributable to the divestiture of certain European assets.

Impairments—During the first nine months of 2026, we recognized impairment charges totaling $89 million, including $74 million recognized in the second quarter related to a plastic waste sorting facility in Houston, Texas, within our O&P-Americas segment. The remaining impairment charges relate to property, plant and equipment in our O&P-EAI segment.

During the first nine months of 2025, we recognized impairment charges of $1,234 million, including $972 million of Goodwill impairments and $262 million of Other impairments. These impairment charges were largely due to the prolonged downturn in, and outlook for, the European petrochemical and global automotive industries, particularly affecting our O&P-EAI and APS segments, combined with the sustained decline in our market capitalization.

See Note 13 to the Consolidated Financial Statements for additional information on impairments.

Selling, General and Administrative (“SG&A”) Expenses—SG&A expenses decreased by $45 million, or 4%, in the first nine months of 2026 compared to the first nine months of 2025, reflecting lower employee-related expenses as a result of our cash improvement plan.

Operating Income (Loss)—Operating income decreased by $476 million, or 31%, in the third quarter of 2026 compared to the second quarter of 2026. Operating income in our O&P-Americas, O&P-EAI, Technology, and APS segments decreased by $534 million, $205 million, $45 million, and $44 million, respectively. These decreases were partially offset by a $346 million increase in our I&D segment.

Operating income increased by $3,181 million in the first nine months of 2026 compared to the first nine months of 2025. Operating income in our O&P-Americas, APS, I&D, O&P-EAI, and Technology segments increased by $1,141 million, $846 million, $664 million, $516 million, and $20 million, respectively.

Results for each of our business segments are discussed further in the “Segment Analysis” section below.

Interest expense—Interest expense increased by $59 million, or 17%, in the first nine months of 2026 compared to the first nine months of 2025, due to a full nine months of interest incurred on the $1.5 billion aggregate principal amount of guaranteed notes issued in November 2025.

Loss on Sale of Business—In the second quarter of 2026, we divested select European olefins and polyolefins assets and the associated businesses and recognized a pre-tax loss of $734 million. See Note 13 to the Consolidated Financial Statements for additional information.

Other Income, Net—Other income decreased by $53 million, or 95%, in the third quarter of 2026 compared to the second quarter of 2026, reflecting the absence of a $52 million gain from the sale of excess European emissions credits recognized in the second quarter of 2026.

Other income increased by $21 million, or 44%, in the first nine months of 2026 compared to the first nine months of 2025, due to the $52 million gain from the sale of excess European emissions credits recognized in the second quarter of 2026, partially offset by the impact of a $36 million gain on the sale of precious metals recognized in the second quarter of 2025.

Income from Equity Investments—Income from equity investments decreased by $55 million, or 96%, in the third quarter of 2026 compared to the second quarter of 2026, due to unfavorable margins relative to the prior quarter and increased by $54 million in the first nine months of 2026 compared to the first nine months of 2025, primarily reflecting improved margins as industry supply was constrained due to the conflict in the Middle East.

Income Taxes—Our effective income tax rate for the third quarter of 2026 was 19.4% compared to 29.2% for the second quarter of 2026. The decrease was primarily driven by the impact of the divestiture of select European assets and the associated businesses, which is largely nondeductible for tax and was recognized discretely in the second quarter of 2026, that decreased the effective income tax rate by 14.1 percentage points. This decrease was partially offset by changes in earnings in countries with varying statutory tax rates, which increased the effective income tax rate in the third quarter of 2026 by 3.6 percentage points.

Our effective income tax rate for the first nine months of 2026 was 22.1% compared to (13.6)% for the first nine months of 2025. The increase was primarily attributable to non-cash impairments recognized in 2025, for which there was largely no tax benefit, changes in earnings in countries with varying statutory tax rates, and the largely nondeductible divestiture of select European assets and related businesses in 2026, which increased the effective income tax rate by 36.7, 12.9 and 6.4 percentage points, respectively. These increases were partially offset by the establishment in 2025 of a valuation allowance against deferred tax assets in the United Kingdom, for which no tax benefit could be recognized, and fluctuations in foreign exchange gains and losses, which decreased the effective income tax rate by 15.0 and 3.9 percentage points, respectively.

Income (Loss) from Discontinued Operations, Net of Tax—Income (loss) from discontinued operations decreased $98 million in the first nine months ended September 30, 2026 compared to the first nine months ended September 30, 2025, primarily due to the recognition of a last-in, first-out (“LIFO”) benefit of $196 million, net of tax, for the liquidation of low cost inventory in the first quarter of 2025. This benefit was partially offset by the net loss of $32 million related to our Berre refinery largely driven by the recognition of an environmental reserve in the third quarter of 2025. The remainder of the change was driven by a reduction in costs as we ceased business operations at our Houston refinery in February 2025.

Comprehensive Income—Comprehensive income (loss) decreased by $44 million in the third quarter of 2026 compared to the second quarter of 2026, primarily reflecting the reclassification of $329 million of cumulative currency translation adjustments from Accumulated other comprehensive loss to Loss on sale of business upon the May 2026 divestiture of select European olefins and polyolefins assets and the associated businesses, partially offset by increases in Net income (loss) and financial derivatives.

Financial derivatives designated as cash flow hedges, primarily our commodity swaps, led to an increase in Comprehensive income (loss) of $39 million in the third quarter of 2026 compared to the second quarter of 2026 reflecting commodity price volatility.

Comprehensive income (loss) increased by $2,178 million in the first nine months of 2026 compared to the first nine months of 2025, primarily due to the increase in Net income (loss).

Segment Analysis

We use net income (loss) before interest, income taxes, and depreciation and amortization (“EBITDA”) as our measure of profitability for segment reporting purposes. This measure of segment operating results is used by our chief operating decision maker to assess the performance of, and allocate resources to, our operating segments. Intersegment eliminations and items that are not directly related or allocated to business operations, such as foreign exchange gains or losses and components of pension and other postretirement benefits other than service costs are included in “Other”. See the table below for a reconciliation of EBITDA to its nearest generally accepted accounting principles (“GAAP”) measure.

The following table presents the reconciliation of Net income (loss) to EBITDA for each of the periods presented:

Three Months EndedNine Months Ended
September 30,June 30,September 30,September 30,
Millions of dollars2026202620262025
Net income (loss)$758$559$1,442$(598)
Provision for income taxes18323240991
Depreciation and amortization3703471,0591,005
Interest expense, net109114330283
EBITDA$1,420$1,252$3,240$781

Our continuing operations are managed through five reportable segments: O&P-Americas, O&P-EAI, I&D, APS, and Technology. Revenues and other information by segment for the periods presented are reflected in the tables below:

Three Months EndedNine Months Ended
September 30,June 30,September 30,September 30,
Millions of dollars2026202620262025
Sales and other operating revenues:
O&P-Americas segment$3,180$3,521$9,138$7,464
O&P-EAI segment2,1762,9557,6327,891
I&D segment2,9832,7477,7906,916
APS segment9351,0102,8212,695
Technology segment114167387372
Other, including intersegment eliminations(889)(1,223)(2,895)(2,276)
Total$8,499$9,177$24,873$23,062
Operating income (loss):
O&P-Americas segment$469$1,003$1,614$473
O&P-EAI segment(47)15843(473)
I&D segment6142681,000336
APS segment1357108(738)
Technology segment18638868
Other, including intersegment eliminations—(6)(4)2
Total$1,067$1,543$2,849$(332)
Three Months EndedNine Months Ended
September 30,June 30,September 30,September 30,
Millions of dollars2026202620262025
Depreciation and amortization:
O&P-Americas segment$162$163$489$484
O&P-EAI segment7146160119
I&D segment105108317307
APS segment21206163
Technology segment11103232
Total$370$347$1,059$1,005
Income (loss) from equity investments:
O&P-Americas segment$9$18$36$17
O&P-EAI segment(7)3917(17)
I&D segment—12—
APS segment—(1)(1)—
Total$2$57$54$—
Impairments:
O&P-Americas segment$—$74$74$9
O&P-EAI segment——15443
APS segment———782
Total$—$74$89$1,234
Loss on sale of business:
O&P-EAI segment$—$(734)$(734)$—
APS segment———(6)
Total$—$(734)$(734)$(6)
Other income (expense), net:
O&P-Americas segment$1$(1)$12$8
O&P-EAI segment959739
I&D segment1—240
APS segment31413
Other, including intersegment eliminations(11)(3)(22)(22)
Total$3$56$69$48
EBITDA:
O&P-Americas segment$641$1,183$2,151$982
O&P-EAI segment26(432)(441)(362)
I&D segment7203771,321683
APS segment3777172(668)
Technology segment2973120100
Discontinued operations(22)(17)(57)66
Other, including intersegment eliminations(11)(9)(26)(20)
Total$1,420$1,252$3,240$781

Olefins and Polyolefins-Americas Segment

Overview—EBITDA decreased in the third quarter of 2026 compared to the second quarter of 2026 and increased in the first nine months of 2026 compared to the first nine months of 2025 due to margin changes resulting from pricing volatility associated with supply disruptions from the conflict in the Middle East.

*Ethylene Raw Materials—*We have flexibility to vary the raw material mix and process conditions in our United States (“U.S.”) olefins plants to maximize profitability as market prices fluctuate for both feedstocks and products. Although prices of crude-based liquids and natural gas liquids are generally related to crude oil and natural gas prices, during specific periods the relationships among these materials and benchmarks may vary significantly. During 2025 and 2026, approximately 70% to 80% of the raw materials used in our North American crackers was ethane.

The following table sets forth selected financial information for the O&P-Americas segment including Income from equity investments, which is a component of EBITDA:

Three Months EndedNine Months Ended
September 30,June 30,September 30,September 30,
Millions of dollars2026202620262025
Sales and other operating revenues$3,180$3,521$9,138$7,464
Income from equity investments9183617
EBITDA6411,1832,151982

Revenue—Revenues for our O&P-Americas segment decreased by $341 million, or 10%, in the third quarter of 2026 compared to the second quarter of 2026 and increased by $1,674 million, or 22%, in the first nine months of 2026 compared to the first nine months of 2025.

Third quarter of 2026 versus second quarter of 2026—Lower average sales prices from softening market conditions relative to the prior quarter resulted in a 19% decrease in revenue. Higher sales volumes driven by increased co-product sales led to a 9% increase in revenue.

First nine months of 2026 versus first nine months of 2025—Higher average sales prices from industry supply disruptions led to a 17% increase in revenue. Higher sales volumes driven by increased co-product sales drove a 5% increase in revenue.

EBITDA—EBITDA decreased by $542 million, or 46%, in the third quarter of 2026 compared to the second quarter of 2026 and increased by $1,169 million, or 119%, in the first nine months of 2026 compared to the first nine months of 2025.

Third quarter of 2026 versus second quarter of 2026—EBITDA declined primarily due to lower margins from softening prices and market conditions relative to the second quarter of 2026, reflecting pricing volatility associated with the conflict in the Middle East.

First nine months of 2026 versus first nine months of 2025—EBITDA improved due to margin improvements as prices increased due to the conflict in the Middle East.

Olefins and Polyolefins-Europe, Asia, International Segment

Overview—During the second quarter of 2026, we recognized a loss on the divestiture of certain European olefins and polyolefins assets and the related businesses. As a result, EBITDA increased in the third quarter of 2026 compared to the second quarter of 2026, despite weaker olefin and polyolefin results during the quarter.

Olefin and polyolefin margins improved in the first nine months of 2026 compared to the first nine months of 2025, primarily due to industry supply constraints associated with the conflict in the Middle East. Additionally, we recognized impairment charges during the first nine months of 2025.

Ethylene Raw Materials—In Europe, naphtha is the primary raw material for our ethylene production and represented approximately 70% to 75% of the raw materials used in 2025 and 2026.

The following table sets forth selected financial information for the O&P-EAI segment including Income (loss) from equity investments, which is a component of EBITDA:

Three Months EndedNine Months Ended
September 30,June 30,September 30,September 30,
Millions of dollars2026202620262025
Sales and other operating revenues$2,176$2,955$7,632$7,891
Income (loss) from equity investments(7)3917(17)
EBITDA26(432)(441)(362)

Revenue—Revenues decreased by $779 million, or 26%, in the third quarter of 2026 compared to the second quarter of 2026 and by $259 million, or 3%, in the first nine months of 2026 compared to the first nine months of 2025.

Third quarter of 2026 versus second quarter of 2026—Lower average sales prices due to easing of supply constraints relative to the prior quarter drove a 15% decrease in revenue. Lower sales volumes resulted in a revenue decrease of 10% driven mostly by the second quarter divestiture of certain European assets. Unfavorable foreign exchange impacts resulted in a 1% decrease in revenue.

First nine months of 2026 versus first nine months of 2025—Higher average sales prices as a result of constrained market supply drove a 12% increase in revenue. Lower sales volumes resulted in a decrease of 19% in revenue primarily due to the second quarter divestiture of certain European assets. Favorable foreign exchange impacts resulted in a 4% increase in revenue.

EBITDA—EBITDA increased by $458 million, or 106%, in the third quarter of 2026 compared to the second quarter of 2026 and decreased by $79 million, or 22%, in the first nine months of 2026 compared to the first nine months of 2025.

During the third quarter of 2025, we recognized a $400 million goodwill impairment charge related to a prolonged downturn in, and outlook for, the European petrochemical industry.

During the second quarter of 2026, we recognized a $734 million loss related to the divestiture of certain European olefins and polyolefins assets and the associated businesses. The disposed sites represented approximately 25% of the production capacity for the O&P-EAI segment. See Note 13 to our Consolidated Financial Statements for additional information.

Third quarter of 2026 versus second quarter of 2026—Despite lower results across all businesses, EBITDA increased due to the loss on divestiture recognized in the second quarter of 2026. Polymer results reduced EBITDA by 30% as margins declined due to lower prices reflecting market volatility related to the conflict in the Middle East. Olefins results reduced EBITDA by 15% driven by lower volumes as a result of the divestiture of certain European assets and related businesses. In addition, lower equity income decreased EBITDA by 11% due to unfavorable margins. Additionally, EBITDA decreased 12% as a result of a $52 million gain on sale of excess European emission credits recognized in the second quarter of 2026.

First nine months of 2026 versus first nine months of 2025—EBITDA decreased primarily due to the $734 million loss on divestiture recognized during the second quarter of 2026. This was partially offset by the $400 million goodwill impairment charge recognized in the nine months ended September 30, 2025. Olefins and polymer results increased EBITDA by 7% and 33%, respectively, driven by higher margins resulting from industry supply constraints associated with the Middle East conflict. EBITDA also benefited from a $52 million gain on the sale of excess European emission credits in the second quarter of 2026.

Intermediates and Derivatives Segment

Overview—EBITDA increased in the third quarter of 2026 compared to the second quarter of 2026 driven by improved oxyfuels and related product results. EBITDA increased in the first nine months of 2026 compared to the first nine months of 2025 as a result of improved margins for the segment.

The following table sets forth selected financial information for the I&D segment including Income from equity investments, which is a component of EBITDA:

Three Months EndedNine Months Ended
September 30,June 30,September 30,September 30,
Millions of dollars2026202620262025
Sales and other operating revenues$2,983$2,747$7,790$6,916
Income from equity investments—12—
EBITDA7203771,321683

Revenue—Revenues increased by $236 million, or 9%, in the third quarter of 2026 compared to the second quarter of 2026 and by $874 million, or 13%, in the first nine months of 2026 compared to the first nine months of 2025.

Third quarter of 2026 versus second quarter of 2026—Higher sales volumes due to higher demand and the successful restart of our Bayport PO/TBA site, resulted in a 15% increase in revenue. Lower average sales prices for propylene oxide and derivatives and styrene drove a 6% decrease in revenue from softening market conditions.

First nine months of 2026 versus first nine months of 2025—Higher average sales prices resulted in a 21% increase in revenue driven primarily by oxyfuels and related products as a result of higher crude and gasoline crack spreads. A decrease in sales volumes due to unplanned outages resulted in a 9% decrease in revenue. Favorable foreign exchange impacts resulted in a 1% increase in revenue.

EBITDA—EBITDA increased by $343 million, or 91%, in the third quarter of 2026 compared to the second quarter of 2026 and by $638 million, or 93%, in the first nine months of 2026 compared to the first nine months of 2025.

Third quarter of 2026 versus second quarter of 2026—Higher oxyfuels and related products results increased EBITDA by 93% driven equally by improved margins from stronger gasoline crack spreads and higher volumes following the restart of the Bayport PO/TBA site after a second quarter outage.

First nine months of 2026 versus first nine months of 2025—Oxyfuels and related products results led to a 55% increase in EBITDA driven by improved margins as a result of higher crude and gasoline crack spreads. Propylene oxide and derivatives results led to a 26% increase in EBITDA primarily due to margin expansion resulting from supply constraints driven by the Middle East conflict.

Advanced Polymer Solutions Segment

Overview—EBITDA decreased in the third quarter of 2026 relative to the second quarter of 2026 due to weaker demand. The increase in EBITDA for the first nine months of 2026 compared to the first nine months of 2025 was primarily attributable to impairment charges recorded in the first nine months of 2025.

The following table sets forth selected financial information for the APS segment including Loss from equity investments, which is a component of EBITDA:

Three Months EndedNine Months Ended
September 30,June 30,September 30,September 30,
Millions of dollars2026202620262025
Sales and other operating revenues$935$1,010$2,821$2,695
Loss from equity investments—(1)(1)—
EBITDA3777172(668)

Revenue—Revenues decreased by $75 million, or 7%, in the third quarter of 2026 compared to the second quarter of 2026 and increased by $126 million, or 5%, in the first nine months of 2026 compared to the first nine months of 2025.

Third quarter of 2026 versus second quarter of 2026—Sales volumes decreased resulting in a 9% decrease in revenue stemming from lower demand. Higher average sales prices as a result of constrained market supply drove a 3% increase in revenue. Unfavorable foreign exchange impacts resulted in a 1% decrease in revenue.

First nine months of 2026 versus first nine months of 2025—Higher average sales prices resulted in an 8% increase in revenue driven by industry supply constraints due to the conflict in the Middle East. Sales volumes decreased resulting in a 5% decrease in revenue due to weaker demand. Favorable foreign exchange impacts resulted in a 2% increase in revenue.

EBITDA—EBITDA decreased by $40 million, or 52%, in the third quarter of 2026 compared to the second quarter of 2026 and increased by $840 million, or 126%, in the first nine months of 2026 compared to the first nine months of 2025.

Third quarter of 2026 versus second quarter of 2026—The decline in EBITDA is attributable to lower volumes driven by weaker automotive demand.

First nine months of 2026 versus first nine months of 2025—In the third quarter of 2025, we recognized impairment charges of $782 million related to a prolonged downturn in, and outlook for, the global automotive industry. There were no similar charges recognized in 2026. The remaining change was driven by improved margins primarily related to higher average sales prices due to industry supply constraints driven by the Middle East conflict.

Technology Segment

Overview—EBITDA decreased in the third quarter of 2026 compared to the second quarter of 2026 due to lower catalyst and licensing results. EBITDA increased in the first nine months of 2026 compared to the first nine months of 2025 driven by higher catalyst results.

The following table sets forth selected financial information for the Technology segment:

Three Months EndedNine Months Ended
September 30,June 30,September 30,September 30,
Millions of dollars2026202620262025
Sales and other operating revenues$114$167$387$372
EBITDA2973120100

Revenue—Revenues decreased by $53 million, or 32%, in the third quarter of 2026 compared to the second quarter of 2026 and increased by $15 million, or 4%, in the first nine months of 2026 compared to the first nine months of 2025.

Third quarter of 2026 versus second quarter of 2026—Lower catalyst sales volumes resulted in a 16% decrease in revenue due to a decline in demand. Lower average catalyst sales price resulted in a 2% decrease in revenue. Lower licensing contract revenue drove a 14% decrease in revenue.

First nine months of 2026 versus first nine months of 2025—Higher catalyst sales volumes resulted in a 2% increase in revenue from increased demand. Lower average catalyst sales price resulted in a 1% decrease in revenue. Lower licensing contract revenue drove a 1% decrease in revenue. Favorable foreign exchange impacts resulted in a 4% increase in revenue.

EBITDA—EBITDA decreased by $44 million, or 60%, in the third quarter of 2026 compared to the second quarter of 2026 and increased by $20 million, or 20%, in the first nine months of 2026 compared to the first nine months of 2025.

Third quarter of 2026 versus second quarter of 2026—Lower licensing results led to a 33% decrease in EBITDA as more contracts with lower average values reached significant milestones. Lower catalyst volumes driven by lower demand led to a 29% decrease in EBITDA.

First nine months of 2026 versus first nine months of 2025—Increased catalyst margins from lower costs resulted in an 11% increase in EBITDA. Favorable foreign exchange impacts resulted in an 8% increase in EBITDA.

FINANCIAL CONDITION

The following table summarizes operating, investing and financing cash flow activities:

Nine Months Ended September 30,
Millions of dollars20262025
Cash provided by (used in):
Operating activities$2,199$755
Investing activities(1,106)(1,373)
Financing activities(1,274)(1,046)

Operating Activities—Cash provided by operating activities of $2,199 million in the first nine months of 2026 primarily reflected earnings adjusted for non-cash items offset by cash activities related to Accounts receivable, Inventories and Accounts payable. An increase in Accounts receivable of $1,440 million was driven by higher average sales prices reflecting higher crude pricing. The increase of $514 million in Inventories was primarily due to an inventory volume increase coupled with increased prices. The increase of $744 million in Accounts payable was primarily driven by higher feedstock prices and volumes.

Cash provided by operating activities of $755 million in the first nine months of 2025 primarily reflected net loss adjusted for non-cash items, $385 million of tax payments which included $235 million in U.S. Federal corporate income tax payments deferred from 2024 into 2025 under Hurricane Beryl disaster relief, and a $583 million change in Accounts payable which was driven by the timing of payments.

Investing Activities—Capital expenditures in the first nine months of 2026 and 2025 totaled $842 million and $1,428 million, respectively, of which approximately 65% supported sustaining maintenance, including turnaround activities at several sites, as well as other plant health, safety and environmental projects. The remaining expenditures supported profit-generating growth projects.

In May 2026, we disposed of select European olefins and polyolefins assets and the associated businesses. In connection with the sale, we made a cash contribution of $310 million to the divested group. See Note 13 to our Consolidated Financial Statements for additional information.

In the first nine months of 2025, foreign currency contracts with an aggregate notional value of €750 million expired. Upon settlement of these foreign currency contracts, we paid €750 million ($877 million at the expiry spot rate) to our counterparties and received $843 million from our counterparties. Additionally, we received $59 million upon termination and cash settlement of our cross-currency interest rate swaps, designated as net investment hedges, maturing in 2025 and 2030.

Financing Activities—We made dividend payments totaling $672 million and $1,321 million in the first nine months of 2026 and 2025, respectively. The decrease reflects our February 2026 announcement to reduce our quarterly dividend.

In September 2026, we repaid the €500 million ($577 million) 0.875% guaranteed notes due 2026.

In May 2025, we issued $500 million of 6.150% guaranteed notes due 2035. Net proceeds from the sale of the notes were used for general corporate purposes, including the repayment of guaranteed notes that were due in October 2025. Additionally, we made payments of $201 million to repurchase outstanding ordinary shares in the first nine months of 2025.

Liquidity and Capital Resources

Overview

We plan to fund our working capital, capital expenditures, debt service, dividends and other cash requirements with our current available liquidity and cash from operations, which could be affected by general economic, financial, competitive, legislative, regulatory, business and other factors, many of which are beyond our control.

Debt repayment, and the purchase of shares under our share repurchase authorization, may be funded from cash and cash equivalents, cash from short-term investments, cash from operating activities, proceeds from the issuance of debt, or a combination thereof.

Cash and Liquid Investments

As of September 30, 2026, we had Cash and cash equivalents totaling $3,227 million, which includes $1,406 million in jurisdictions outside of the U.S., the majority of which is held within the European Union and the United Kingdom. There are currently no legal or economic restrictions that would materially impede our transfers of cash.

Credit Arrangements

As of September 30, 2026, we had total debt, including current maturities, of $12,331 million. Additionally, we had $175 million of outstanding letters of credit, bank guarantees and surety bonds issued under uncommitted credit facilities.

We had total unused availability under our credit facilities of $4,450 million as of September 30, 2026. For additional details regarding our credit facilities see Note 7 to the Consolidated Financial Statements.

At any time and from time to time, we may repay or redeem our outstanding debt, including purchases of our outstanding bonds in the open market, through privately negotiated transactions or a combination thereof, in each case using cash and cash equivalents, cash from our short-term investments, cash from operating activities, proceeds from the issuance of debt or proceeds from asset divestitures. Any repayment or redemption of our debt will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. In connection with such repurchases or redemptions, we may incur cash and non-cash charges, which could be material in the period in which they are incurred.

Share Repurchases

As of October 28, 2026, we had approximately 34.0 million shares remaining under the current authorization. The timing and amounts of additional shares repurchased, if any, will be determined based on our evaluation of market conditions and other factors, including any additional authorizations approved by our shareholders. For additional information related to our share repurchase authorizations, see Note 11 to the Consolidated Financial Statements.

CURRENT BUSINESS OUTLOOK

Conditions in the Middle East are likely to remain fluid and a potential return to pre-conflict conditions is likely to be non-linear and take longer than anticipated. Customer buying patterns have been impacted by inventory levels and price volatility, however polyethylene domestic and export demand is strong and polymer pricing improved through the end of the third quarter. Additionally, oxyfuels margins and demand remain strong. As markets continue to adjust, reliable supply and operational flexibility are expected to remain important differentiators.

In the fourth quarter, we expect normal seasonal demand patterns along with ongoing supply uncertainty. We have a planned maintenance project in a North American polypropylene asset. To align with global demand and the Company's planned maintenance, we expect fourth quarter operating rates of 85% for O&P-Americas assets, 60% for European O&P-EAI assets and 75% for I&D assets. The fourth quarter is expected to deliver a seasonal release of working capital.

We remain focused on commercial and operational agility in this dynamic market while continuing to execute the cash improvement plan. Our capital allocation priorities remain unchanged: safely operate and maintain assets, strengthen the balance sheet through disciplined deleveraging, maintain an attractive dividend and invest selectively in opportunities that enhance long-term shareholder value.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

*Inventory—*As of December 31, 2025, three of our nine LIFO inventory pools, with a combined carrying value of $1.6 billion, were valued close to their respective market values. Due to increases in market prices during the first nine months of 2026, none of our LIFO inventory pools were at risk for lower of cost or market adjustments.

ACCOUNTING AND REPORTING CHANGES

For a discussion of the potential impact of new accounting pronouncements on the Consolidated Financial Statements, see Note 2 to the Consolidated Financial Statements.

CAUTIONARY STATEMENT FOR THE PURPOSES OF THE “SAFE HARBOR” PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

This report includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”). You can identify our forward-looking statements by the words “anticipate,” “estimate,” “believe,” “continue,” “could,” “intend,” “may,” “plan,” “potential,” “predict,” “should,” “will,” “expect,” “objective,” “projection,” “forecast,” “goal,” “guidance,” “outlook,” “effort,” “target” and similar expressions.

We based forward-looking statements on our current expectations, estimates and projections of our business and the industries in which we operate. We caution you that these statements are not guarantees of future performance. They involve assumptions about future events that, while made in good faith, may prove to be incorrect, and involve risks and uncertainties we cannot predict. Our actual outcomes and results may differ materially from what we have expressed or forecast in the forward-looking statements. Any differences could result from a variety of factors, including the following:

  • the cost of raw materials represents a substantial portion of our operating expenses, and energy costs generally follow price trends of crude oil, natural gas liquids and/or natural gas; price volatility can significantly affect our results of operations and we may be unable to pass raw material and energy cost increases on to our customers due to the significant competition that we face, the commodity nature of our products and the time required to implement pricing changes;

  • our operations in the United States (“U.S.”) have benefited from low-cost natural gas and natural gas liquids; decreased availability of these materials (for example, from their export or regulations impacting hydraulic fracturing in the U.S.) could reduce the current benefits we receive;

  • if crude oil prices are low relative to U.S. natural gas prices, we could see less benefit from low-cost natural gas and natural gas liquids and it could have a negative effect on our results of operations;

  • industry production capacities and operating rates may lead to periods of oversupply and low profitability and our future operating and financial results are dependent on the pace of global capacity rationalization;

  • we may face unplanned operating interruptions (including leaks, explosions, fires, weather-related incidents, mechanical failures, unscheduled downtime, supplier disruptions, labor shortages, strikes, work stoppages or other labor difficulties, transportation interruptions, spills and releases and other environmental incidents) at any of our facilities, which would negatively impact our operating results;

  • changes in general economic, business, political and regulatory conditions in the countries or regions in which we operate could increase our costs through tariffs or otherwise, limit or disrupt trade, restrict our operations and reduce our operating results;

  • our ability to execute our organic growth plans may be negatively affected by our ability to complete projects on time and on budget;

  • the successful outcome of any planned sale of our assets, or our ability to acquire or dispose of product lines or businesses could disrupt our business and harm our financial condition;

  • uncertainties associated with worldwide economic conditions, including those resulting from geopolitical instability and global supply disruptions related to ongoing conflicts such as those in Ukraine and the Middle East could adversely affect demand, pricing, and supply chain reliability, increase counterparty and credit risks, and impact the Company’s liquidity, financial condition, and results of operations;

  • the negative outcome of any legal, tax and environmental proceedings or changes in laws or regulations regarding legal, tax and environmental matters may increase our costs, reduce demand for our products, or otherwise limit our ability to achieve savings under current regulations;

  • any loss or non-renewal of favorable tax treatment under tax agreements or tax treaties, or changes in tax laws, regulations or treaties, may substantially increase our tax liabilities;

  • we may be required to reduce production or idle certain facilities because of the cyclical and volatile nature of the supply-demand balance in the chemical industries, which would negatively affect our operating results;

  • we rely on continuing technological innovation, and an inability to protect our technology, or others’ technological developments could negatively impact our competitive position;

  • we have significant international operations, and fluctuations in exchange rates, valuations of currencies and our possible inability to access cash from operations in certain jurisdictions on a tax-efficient basis, if at all, could negatively affect our liquidity and our results of operations;

  • we are subject to the risks of doing business at a global level, including wars, terrorist activities, political and economic instability and disruptions and changes in governmental policies, which could cause increased expenses, decreased demand or prices for our products and/or disruptions in operations, all of which could reduce our operating results;

  • if we are unable to achieve our emission reduction, circularity, or other sustainability targets, it could result in reputational harm, changing investor sentiment regarding investment in our stock or a negative impact on our access to and cost of capital;

  • our ability to execute and achieve the expected results of our value enhancement program and cash improvement plan;

  • our ability to maintain our investment-grade credit rating and execute our capital allocation strategy, including our ability to pay dividends;

  • if we are unable to comply with the terms of our credit facilities, indebtedness and other financing arrangements, those obligations could be accelerated, which we may not be able to repay; and

  • we may be unable to incur additional indebtedness or obtain financing on terms that we deem acceptable, including for refinancing of our current obligations; higher interest rates and costs of financing would increase our expenses.

Any of these factors, or a combination of these factors, could materially affect our future results of operations and the ultimate accuracy of the forward-looking statements. Our management cautions against putting undue reliance on forward-looking statements or projecting any future results based on such statements or present or prior earnings levels.

All subsequent written and oral forward-looking statements attributable to us or any person acting on our behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this section and any other cautionary statements that may accompany such forward-looking statements. Except as otherwise required by applicable law, we disclaim any duty to update any forward-looking statements.

Previous: Item 1. CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) · Next: Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK